Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 8 de 8
Filter
1.
High Blood Press Cardiovasc Prev ; 25(4): 421-424, 2018 Dec.
Article in English | MEDLINE | ID: mdl-30298226

ABSTRACT

Guillain-Barré syndrome (GBS) may be complicated by severe hypertension (HT) and in turns severe HT can occur with neurological damage mimicking a GBS, so that underlying causes should be investigated. We describe a case of a 62-year-old woman presented to the emergency department for hypertensive crisis with symmetric flaccid paralysis, hypotonia and hyporeflexia of both upper and lower limbs. Brain computed tomography, magnetic resonance imaging and lumbar puncture were normal. Laboratory investigations revealed severe hypokalemia, renal failure, liver impairment, rabdomyolysis, metabolic alkalosis, and low plasma renin and aldosterone levels. Continuous potassium replacement led to complete clinical resolution. A detailed history revealed chronic intake of 250 g/day black liquorice. Hypokalaemic muscle weakness may simulate a GBS. When serum potassium level falls below 2.5 mmol/l, rhabdomyolysis may occur. In this clinical case, an apparent mineralocorticoid excess syndrome was induced by chronic ingestion of liquorice. This latter contains the glycyrrhetic acid that inhibits the enzyme 11-ß-hydroxysteroid dehydrogenase enzyme type-2 leading an aldosterone-like effect and causing hypertension, hypokalemia, metabolic alkalosis and low renin values. The clinical presentation is similar to that observed in the primary aldosteronism, but in this syndrome plasma aldosterone levels are low rather than elevated as in primary aldosteronism. Liquorice-induced hypertension with severe hypokalemia and rhabdomyolysis is a rare condition and the initial presentation with acute muscle paralysis is still more unusual. Before performing instrumental examinations in middle-aged peoples with hypertension crisis and neurological impairment, a detailed clinical history is mandatory.


Subject(s)
Blood Pressure , Glycyrrhiza/adverse effects , Guillain-Barre Syndrome/diagnosis , Hypertension/chemically induced , Hypokalemia/chemically induced , Paralysis/chemically induced , Rhabdomyolysis/chemically induced , Diagnosis, Differential , Female , Guillain-Barre Syndrome/physiopathology , Humans , Hypertension/diagnosis , Hypertension/physiopathology , Hypertension/therapy , Hypokalemia/diagnosis , Hypokalemia/physiopathology , Hypokalemia/therapy , Middle Aged , Paralysis/diagnosis , Paralysis/physiopathology , Paralysis/therapy , Predictive Value of Tests , Rhabdomyolysis/diagnosis , Rhabdomyolysis/physiopathology , Rhabdomyolysis/therapy , Risk Factors , Severity of Illness Index
2.
High Blood Press Cardiovasc Prev ; 23(1): 41-6, 2016 Mar.
Article in English | MEDLINE | ID: mdl-26729327

ABSTRACT

INTRODUCTION: Resistant hypertension is a clinical condition in which blood pressure (BP) control is not achieved under a pharmacological therapy including a diuretic and at least two additional antihypertensive drug classes. AIM: To discuss an unusual presentation of uncontrolled hypertension despite multiple anti-hypertensive medications. METHODS AND RESULTS: A 46-year-old woman presented with resistant hypertension (HT) and with a long history of polydipsia, polyuria, weight loss and psychiatric symptoms (sudden onset of personality disorder with free anxiety, negativism and asthenia) unsuccessfully treated with antidepressant drugs. Tests for secondary HT showed a marked increase of serum renin and aldosterone both in clinostatic (342 pg/ml and 907 pmol/l, respectively) and orthostatic posture (351 pg/ml and 2845 pmol/l, respectively), hypokalemia (2.9 mmol/l) and macroalbuminuria (431 mg/day). Diagnostic examinations also revealed a focal stenosis of approximately 70 % of the proximal right renal artery with post-stenotic dilation. After percutaneous balloon angioplasty and stent implantation, BP was normalized with 5 mg/day amlodipine and psychiatric symptoms suddenly disappeared. CONCLUSIONS: Psychopathological symptoms are rare at the onset of hyperaldosteronism, and their aetiology is not well defined. A proper diagnostic and therapeutic process is mandatory in order to get the recommended therapeutic targets in short-midterm improving long-term prognosis. We also suggest not considering depressed or treat with antidepressant agents a young hypertensive subject with uncontrolled hypertension despite multiple anti-hypertensive medications without having ruled out a secondary form of hypertension.


Subject(s)
Affect , Blood Pressure , Hyperaldosteronism/etiology , Hypertension, Renovascular/etiology , Mood Disorders/etiology , Renal Artery Obstruction/complications , Angioplasty, Balloon/instrumentation , Antihypertensive Agents/therapeutic use , Blood Pressure/drug effects , Drug Resistance , Drug Therapy, Combination , Female , Humans , Hyperaldosteronism/diagnosis , Hyperaldosteronism/psychology , Hypertension, Renovascular/diagnosis , Hypertension, Renovascular/therapy , Middle Aged , Mood Disorders/diagnosis , Mood Disorders/psychology , Predictive Value of Tests , Renal Artery Obstruction/diagnosis , Renal Artery Obstruction/therapy , Risk Factors , Stents , Tomography, X-Ray Computed , Treatment Outcome , Ultrasonography, Doppler, Color
3.
Endocrine ; 45(3): 469-78, 2014 Apr.
Article in English | MEDLINE | ID: mdl-23817839

ABSTRACT

Pheochromocytoma (PH) and paraganglioma (PG) are neuroendocrine neoplasms arising from chromaffin cells of the adrenal medulla and the sympathetic ganglia, respectively. Although are unusual cause of hypertension (HT) accounting for at most 0.1-0.2 % of cases, they may lead to severe and potentially lethal hypertensive crisis due to the effects of the released catecholamines. However, both PH and PG may be asymptomatic as ~30 % of subjects are normotensive or have orthostatic hypotension and in these cases the 24 h ambulatory blood pressure (BP) monitoring is an important toll to diagnose and treat HT. HT treatment may be difficult when PH or PG occurs in pregnancy or in the elderly subjects and in these cases a multidisciplinary team is required. When surgical excision is mandatory the perioperative management requires the administration of selective α1-adrenergic blocking agents (i.e., doxazosin, prazosin or terazosin) followed by a ß-adrenergic blockade (i.e., propranolol, atenolol). This latter should never be started first because blockade of vasodilatory peripheral ß-adrenergic receptors with unopposed α-adrenergic receptor stimulation can lead to a further elevation of BP. Although labetalol is traditionally considered the ideal agent due to its α- and ß-adrenergic antagonism, experimental studies do not support its use in this clinical setting. As second regimen, the administration of vasodilators as calcium channel blockers (i.e., nicardipine, nifedipine) may be required to control BP. Oral and sublingual short-acting nifedipine are potentially dangerous in patients with hypertensive emergencies and are not recommend. The latest evidences into the diagnosis and treatment of hypertensive crisis due to PH and PG are reviewed here.


Subject(s)
Adrenal Gland Neoplasms/complications , Adrenergic alpha-Antagonists/therapeutic use , Adrenergic beta-Antagonists/therapeutic use , Antihypertensive Agents/therapeutic use , Calcium Channel Blockers/therapeutic use , Hypertension , Paraganglioma/complications , Humans , Hypertension/diagnosis , Hypertension/drug therapy , Hypertension/etiology , Pheochromocytoma/complications
4.
Int J Hypertens ; 2012: 590683, 2012.
Article in English | MEDLINE | ID: mdl-21949902

ABSTRACT

Arterial hypertension (HT) is age dependent and, with the prolongation of life expectancy, affects more and more elderly people. In the elderly, HT is a risk factor for organ damage and cardiovascular (CV) events. Both pharmacologic and nonpharmacologic reduction of blood pressure (BP) is associated with a corresponding decrease in systolic-diastolic or isolated systolic HT. Clinical trials have shown that BP lowering is associated with a decrease in stroke and other CV events. Therefore, BP reduction per se appears more important than a particular class of antihypertensive drugs. The benefit of antihypertensive treatment has been confirmed up to the age of 80 years, remaining unclear in the octogenarians. The benefit in lowering diastolic BP between 80 and 90 mmHg is well established, while that of lowering systolic BP below 140 mmHg requires further confirmations.

5.
Angiology ; 57(5): 600-6, 2006.
Article in English | MEDLINE | ID: mdl-17067983

ABSTRACT

The authors assessed the prevalence of pulmonary arterial hypertension (PAH) in patients with hyperthyroidism and evaluated the response to treatment of the thyrotoxicosis. They assessed the pulmonary artery systolic pressure (PASP) at rest (estimated by echocardiography) in 23 consecutive patients diagnosed with hyperthyroidism due to Graves' disease or toxic multinodular goiter. Twelve of 23 patients (52%) did not show antithyroglobulin and antithyroperoxidase antibodies. Seventeen patients were followed up for at least 9 months after achieving a stable euthyroid status. Fifteen (65%) patients demonstrated PAH at admission. Four patients were lost to follow-up; therefore they were able to evaluate 17 patients serially with echocardiography. Sixteen patients normalized their PASP value: 13 after methimazole, 2 after total thyroidectomy, and 1 after (131)I treatment. In 1 patient no significant change in PASP was observed. This patient experienced an acute myocardial reinfarction during follow-up. They found a higher prevalence than that previously reported in observational studies. In addition, they demonstrated that the PAH reverses after correction of hyperthyroidism. Elevated PASP at rest on echocardiography may be considered a frequent finding of thyrotoxicosis. Moreover, the data seem not to support an autoimmune pathogenesis for PAH.


Subject(s)
Hypertension, Pulmonary/etiology , Hyperthyroidism/complications , Adult , Aged , Blood Pressure , Female , Humans , Hypertension, Pulmonary/physiopathology , Hyperthyroidism/drug therapy , Hyperthyroidism/physiopathology , Male , Middle Aged , Pulmonary Artery
6.
Biomed Pharmacother ; 60(3): 134-8, 2006 Apr.
Article in English | MEDLINE | ID: mdl-16524690

ABSTRACT

We reported here the data on minimally invasive radio-guided parathyroidectomy (MIRP) in a large group of 253 patients enrolled from the whole series of 355 consecutive patients affected by primary hyperparathyroidism (P-HPT) referred to our center. On the basis of preoperative imaging including Sestamibi scintigraphy and neck ultrasound (US), 263 patients (74% of the whole series) with evidence of a solitary parathyroid adenoma (PA) and a normal thyroid gland were addressed to MIRP and in 253 (96%) of them this minimally invasive neck exploration was successfully performed. The MIRP protocol developed in our center consisted of a very low 1 mCi Sestamibi injection in the operating room a few minutes before the start of intervention, thus minimizing the radiation exposure dose to the patient and personnel. No major intraoperative complication was recorded in patients treated by MIRP and only a transient hypocalcemia in 8.5% of cases. The mean duration time for MIRP was 35 min and the mean hospital stay 1.2 days. Local anesthesia was also performed in 62 patients, 54 of whom were elderly patients with concomitant invalidating diseases contraindicating general anesthesia. No HPT relapse was observed during subsequent follow-up. The gamma probe was used also during bilateral neck exploration in the group of 92 patients excluded from MIRP. The most frequent cause of exclusion from MIRP in our series was the presence of concomitant Sestamibi avid thyroid nodules (68.5% of cases) that can give false positive results at radio-guided surgery. In conclusion, MIRP is an effective treatment in patients with a high likelihood of a solitary PA and a normal thyroid gland at scintigraphy and US so that an accurate preoperative localizing imaging is required for MIRP. A low 1 mCi Sestamibi dose appears sufficient to perform MIRP. Patients with concomitant Sestamibi avid thyroid nodules should be excluded from MIRP.


Subject(s)
Adenoma/surgery , Gamma Cameras , Hyperparathyroidism, Primary/surgery , Minimally Invasive Surgical Procedures , Parathyroid Neoplasms/surgery , Parathyroidectomy , Radiology, Interventional/instrumentation , Adenoma/complications , Adenoma/diagnostic imaging , Adolescent , Adult , Aged , Aged, 80 and over , Female , Humans , Hyperparathyroidism, Primary/diagnostic imaging , Hyperparathyroidism, Primary/etiology , Male , Middle Aged , Parathyroid Neoplasms/complications , Parathyroid Neoplasms/diagnostic imaging , Parathyroidectomy/methods , Patient Selection , Radionuclide Imaging , Radiopharmaceuticals , Technetium Tc 99m Sestamibi , Treatment Outcome
7.
Curr Drug Targets Inflamm Allergy ; 3(4): 459-67, 2004 Dec.
Article in English | MEDLINE | ID: mdl-15584895

ABSTRACT

Secondary pulmonary hypertension (sPH) may develop as a result of few systemic diseases as endocrine diseases, HIV infection, collagen diseases, liver and hematological disorders. In this review we discuss the role of systemic diseases in inducing PH starting from a pathological classification.


Subject(s)
Hypertension, Pulmonary/etiology , Hypertension, Pulmonary/physiopathology , Acquired Immunodeficiency Syndrome/complications , Acquired Immunodeficiency Syndrome/physiopathology , Humans , Hypoxia/complications , Hypoxia/physiopathology , Pulmonary Fibrosis/complications , Pulmonary Fibrosis/physiopathology , Vasculitis/complications , Vasculitis/physiopathology , Vasoconstriction , Ventricular Dysfunction, Right/complications , Ventricular Dysfunction, Right/physiopathology
8.
Thyroid ; 12(9): 829-31, 2002 Sep.
Article in English | MEDLINE | ID: mdl-12481950

ABSTRACT

Retroperitoneal fibrosis is a rare disease of uncertain pathogenesis. However, its possible association with several immunopathologic conditions, the possibility of systemic involvement by the fibrous process, the presence of various autoantibodies, and the frequent response to immunosuppressive treatment all support an autoimmune pathogenesis. Riedel's thyroiditis is a rare disease the pathogenesis of which is also thought to be immune-mediated based on its optimal response to steroids; Riedel's thyroiditis is also frequently reported in association with retroperitoneal fibrosis. We describe here two cases of autoimmune thyroid disease associated with retroperitoneal fibrosis, the first with features of primary myxedema, the second of primary thyrotoxicosis. Histology of retroperitoneal fibrosis is documented and it is compatible with an immunopathologic condition. Thus, these two cases add further support to the hypothesis of an autoimmune pathogenesis of retroperitoneal fibrosis and indicate the importance of carefully monitoring for the development of other autoimmune disorders, i.e., of the thyroid gland, in patients with retroperitoneal fibrosis.


Subject(s)
Graves Disease/complications , Retroperitoneal Fibrosis/etiology , Thyroiditis, Autoimmune/complications , Aged , Female , Humans , Middle Aged , Retroperitoneal Fibrosis/pathology
SELECTION OF CITATIONS
SEARCH DETAIL
...